Tuberculosis remains one of Mozambique’s major public health concerns, with 121,000 people estimated to have developed the disease in 2023. The country also reported 7,700 TB-related deaths and continues to grapple with high levels of TB-HIV co-infection, which affects 28,000 individuals. Drug-resistant TB presents another challenge, with 4,200 cases recorded last year.
Our work in Mozambique began in 2017, when we supported the National Tuberculosis Programme by delivering 3 ultra-portable X-ray systems, each paired with CAD4TB, for use in the national TB prevalence survey. This project included system integration into the national TB database, ensuring digital data continuity.
In 2019, we delivered an additional ultra-portable X-ray system to IOM, along with a solar power installation to support off-grid imaging. By 2021, the Ministry of Health had procured 3 Delft OneStopTB X-ray Clinics through UNOPS, while the IOM added 2 CAD4TB systems to its toolkit.
Efforts scaled significantly in 2022. That year, 54 Delft Light systems, with CAD4TB, were rolled out across ten provinces. Our team provided onsite installation and training in partnership with a local team to strengthen in-country capacity.
In 2023, we delivered 1 CAD4TB via IOM and added 7 more CAD4TB installations across public facilities.
This momentum continued into 2025 with the deployment of 29 CompassDR systems and CAD4TB, which the Ministry of Health procured through PFSCM. Additionally, Fundación Privada Instituto de Salud Global Barcelona facilitated the delivery of a Delft Light. Later that year, the Ministry expanded its scope with the procurement of CAD4Silicosis to better address silicosis detection and care.
